Editorial: Trends in Dengue Evolution, Immune Pathogenesis, and Pathology

Overview

Journal Front Cell Infect Microbiol

Specialties Cell Biology
Infectious Diseases
Microbiology

Date 2023 Jun 12

PMID 37305420

Authors

S Gowri Sankar

A Alwin Prem Anand

Balaji Chattopadhyay

Affiliations

Soon will be listed here.

References

Montoya M, Collins M, Dejnirattisai W, Katzelnick L, Puerta-Guardo H, Jadi R . Longitudinal Analysis of Antibody Cross-neutralization Following Zika Virus and Dengue Virus Infection in Asia and the Americas. J Infect Dis. 2018; 218(4):536-545. PMC: 6047418. DOI: 10.1093/infdis/jiy164. View

Rathore A, St John A . Cross-Reactive Immunity Among Flaviviruses. Front Immunol. 2020; 11:334. PMC: 7054434. DOI: 10.3389/fimmu.2020.00334. View

Calisher C, KARABATSOS N, Dalrymple J, Shope R, PORTERFIELD J, WESTAWAY E . Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. J Gen Virol. 1989; 70 ( Pt 1):37-43. DOI: 10.1099/0022-1317-70-1-37. View

Wilder-Smith A, Ooi E, Horstick O, Wills B . Dengue. Lancet. 2019; 393(10169):350-363. DOI: 10.1016/S0140-6736(18)32560-1. View

Castillo Ramirez J, Urcuqui-Inchima S . Dengue Virus Control of Type I IFN Responses: A History of Manipulation and Control. J Interferon Cytokine Res. 2015; 35(6):421-30. PMC: 4490770. DOI: 10.1089/jir.2014.0129. View

Chancharoenthana W, Leelahavanichkul A, Ariyanon W, Vadcharavivad S, Phatcharophaswattanakul S, Kamolratanakul S . Leaky Gut Syndrome Is Associated with Endotoxemia and Serum (1→3)-β-D-Glucan in Severe Dengue Infection. Microorganisms. 2021; 9(11). PMC: 8625530. DOI: 10.3390/microorganisms9112390. View

Avirutnan P, Hauhart R, Somnuke P, Blom A, Diamond M, Atkinson J . Binding of flavivirus nonstructural protein NS1 to C4b binding protein modulates complement activation. J Immunol. 2011; 187(1):424-33. PMC: 3119735. DOI: 10.4049/jimmunol.1100750. View

Paul L, Carlin E, Jenkins M, Tan A, Barcellona C, Nicholson C . Dengue virus antibodies enhance Zika virus infection. Clin Transl Immunology. 2017; 5(12):e117. PMC: 5192063. DOI: 10.1038/cti.2016.72. View

Sridhar S, Luedtke A, Langevin E, Zhu M, Bonaparte M, Machabert T . Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy. N Engl J Med. 2018; 379(4):327-340. DOI: 10.1056/NEJMoa1800820. View

10.

Gu S, Chen Y, Wu Z, Chen Y, Gao H, Lv L . Alterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 Influenza. Clin Infect Dis. 2020; 71(10):2669-2678. PMC: 7314193. DOI: 10.1093/cid/ciaa709. View

11.

Aguirre S, Luthra P, Sanchez-Aparicio M, Maestre A, Patel J, Lamothe F . Dengue virus NS2B protein targets cGAS for degradation and prevents mitochondrial DNA sensing during infection. Nat Microbiol. 2017; 2:17037. PMC: 7457382. DOI: 10.1038/nmicrobiol.2017.37. View

12.

Morrison J, Aguirre S, Fernandez-Sesma A . Innate immunity evasion by Dengue virus. Viruses. 2012; 4(3):397-413. PMC: 3347034. DOI: 10.3390/v4030397. View

13.

Capeding M, Tran N, Hadinegoro S, Ismail H, Chotpitayasunondh T, Chua M . Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial. Lancet. 2014; 384(9951):1358-65. DOI: 10.1016/S0140-6736(14)61060-6. View

14.

de Madrid A, PORTERFIELD J . The flaviviruses (group B arboviruses): a cross-neutralization study. J Gen Virol. 1974; 23(1):91-6. DOI: 10.1099/0022-1317-23-1-91. View

15.

Avirutnan P, Fuchs A, Hauhart R, Somnuke P, Youn S, Diamond M . Antagonism of the complement component C4 by flavivirus nonstructural protein NS1. J Exp Med. 2010; 207(4):793-806. PMC: 2856034. DOI: 10.1084/jem.20092545. View

16.

Chan Y, Gack M . A phosphomimetic-based mechanism of dengue virus to antagonize innate immunity. Nat Immunol. 2016; 17(5):523-30. PMC: 4837045. DOI: 10.1038/ni.3393. View

17.

Dejnirattisai W, Supasa P, Wongwiwat W, Rouvinski A, Barba-Spaeth G, Duangchinda T . Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus. Nat Immunol. 2016; 17(9):1102-8. PMC: 4994874. DOI: 10.1038/ni.3515. View

18.

Priyamvada L, Quicke K, Hudson W, Onlamoon N, Sewatanon J, Edupuganti S . Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus. Proc Natl Acad Sci U S A. 2016; 113(28):7852-7. PMC: 4948328. DOI: 10.1073/pnas.1607931113. View

19.

Glasner D, Puerta-Guardo H, Beatty P, Harris E . The Good, the Bad, and the Shocking: The Multiple Roles of Dengue Virus Nonstructural Protein 1 in Protection and Pathogenesis. Annu Rev Virol. 2018; 5(1):227-253. PMC: 6311996. DOI: 10.1146/annurev-virology-101416-041848. View

20.

Inoue T, Nakayama J, Moriya K, Kawaratani H, Momoda R, Ito K . Gut Dysbiosis Associated With Hepatitis C Virus Infection. Clin Infect Dis. 2018; 67(6):869-877. DOI: 10.1093/cid/ciy205. View